{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:56:41Z","timestamp":1780055801974,"version":"3.54.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Invasive primary surgical site infections (IP-SSI) are a severe complication of liver transplant surgery. Identification of risk factors for IP-SSI is critical to IP-SSI prevention.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>All adult single liver transplants performed at Duke University Hospital in the period 2015\u20132020 were reviewed for IP-SSI occurring within 90 d of transplant. Risks for IP-SSI were identified using least absolute shrinkage and selection operator variable selection procedure. A 2-sided <jats:italic toggle=\"yes\">P<\/jats:italic> value of &lt;0.05 was considered statistically significant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>IP-SSI were identified in 34\/470 (7.2%) adult single liver transplants. Repeat transplantation, spilt liver, Roux-en-Y biliary anastomosis, anastomotic leak, and post-transplant renal replacement therapy were positively associated with IP-SSI. IP-SSI were associated with increased length of index transplant hospitalization (24.5 versus 10.0 d, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&lt;\u20090.01) and 1-y all-cause mortality (14.7% versus 4.1%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.02). Gram positive bacteria were the main pathogens (51.7%), followed by Gram negative bacteria (24.1%) and <jats:italic toggle=\"yes\">Candida<\/jats:italic> (24.1%). Multidrug resistance bacteria increased over time (27.3% in 2015 versus 66.7% in 2020, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.17).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>In the setting of routine antimicrobial prophylaxis and an overall low rate of IP-SSI, surgical factors were the main determinants of IP-SSI among adult liver transplant recipients. IP-SSI had a negative impact on the length of index transplant hospitalization and 1-y mortality. While the surgical factors associated with an increased risk of IP-SSI are not easily modifiable, their impact may be best contained by close clinical monitoring and tailored antimicrobial therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000001719","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T16:00:11Z","timestamp":1731600011000},"page":"e1719","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Risk Factors for Invasive Surgical Site Infections Among Adult Single Liver Transplant Recipients at Duke University Hospital in the Period 2015\u20132020"],"prefix":"10.1097","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3187-5905","authenticated-orcid":false,"given":"Manuela","family":"Carugati","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Duke University, Durham, NC ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Arif","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Duke University, Durham, NC ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Yarrington","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Duke University, Durham, NC ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay Y.","family":"King","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, Duke University, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Harris","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Duke University, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyla","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Duke University, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Barbas","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Abdominal Transplant Surgery, Duke University, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra L.","family":"Sudan","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Abdominal Transplant Surgery, Duke University, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Duke University, Durham, NC ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara D.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Duke University, Durham, NC ."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"R1-20250313","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1067\/msy.2001.116666","article-title":"The effect of surgical site infections on outcomes and resource utilization after liver transplantation.","volume":"130","author":"Hollenbeak","year":"2001","journal-title":"Surgery"},{"key":"R2-20250313","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/01.TP.0000130178.17216.28","article-title":"Surgical site infection in living-donor liver transplant recipients: A prospective study.","volume":"78","author":"Iinuma","year":"2004","journal-title":"Transplantation"},{"key":"R3-20250313","doi-asserted-by":"crossref","first-page":"e0136559","DOI":"10.1371\/journal.pone.0136559","article-title":"Changes in surgical site infections after living donor liver transplantation.","volume":"10","author":"Yamamoto","year":"2015","journal-title":"PLoS One"},{"key":"R4-20250313","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/lt.23682","article-title":"Surgical site infections in liver transplant recipients in the model for end-stage liver disease era: An analysis of the epidemiology, risk factors, and outcomes.","volume":"19","author":"Freire","year":"2013","journal-title":"Liver Transpl"},{"key":"R5-20250313","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/TP.0b013e3181a25133","article-title":"Surgical site infection after liver transplantation: Risk factors and association with graft loss or death.","volume":"87","author":"Hellinger","year":"2009","journal-title":"Transplantation"},{"key":"R6-20250313","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/lt.21435","article-title":"Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant.","volume":"14","author":"Asensio","year":"2008","journal-title":"Liver Transplant"},{"key":"R7-20250313","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1097\/TP.0b013e3181735407","article-title":"Surgical site infection in liver transplant recipients: impact on the type of perioperative prophylaxis.","volume":"85","author":"Prado","year":"2008","journal-title":"Transplantation"},{"key":"R8-20250313","doi-asserted-by":"crossref","first-page":"e13941","DOI":"10.1111\/tid.13941","article-title":"Epidemiology and outcomes of surgical site infections among pediatric liver transplant recipients.","volume":"24","author":"Banach","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"R9-20250313","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajic.2017.05.021","article-title":"Risk factors for development of surgical site infections among liver transplantation recipients: An integrative literature review.","volume":"46","author":"Oliveira","year":"2018","journal-title":"Am J Infect Control"},{"key":"R10-20250313","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1097\/TP.0000000000001356","article-title":"Surgical site infections after liver transplantation: Emergence of multidrug-resistant bacteria and implications for prophylaxis and treatment strategies.","volume":"100","author":"Viehman","year":"2016","journal-title":"Transplantation"},{"key":"R11-20250313","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1017\/ice.2017.131","article-title":"Surgical site infections after liver transplantation: Prospective surveillance and evaluation of 250 transplant recipients in Canada.","volume":"38","author":"Natori","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R12-20250313","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.transproceed.2020.02.093","article-title":"Surgical site infections in liver transplant patients: A single-center experience.","volume":"52","author":"Hrenczuk","year":"2020","journal-title":"Transplant Proc"},{"key":"R13-20250313","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0032-1301739","article-title":"Infectious complications after orthotopic liver transplantation.","volume":"33","author":"Patel","year":"2012","journal-title":"Semin Respir Crit Care Med"},{"key":"R14-20250313","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.transproceed.2016.02.032","article-title":"Impact of a multimodal approach in prevention of surgical site infection in hepatic transplant recipients.","volume":"48","author":"Prieto","year":"2016","journal-title":"Transplant Proc"},{"key":"R15-20250313","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.transproceed.2015.04.047","article-title":"Bacterial pathogens isolated in liver transplant recipients with surgical site infection and antibiotic treatment.","volume":"47","author":"Avkan-Oguz","year":"2015","journal-title":"Transplant Proc"},{"key":"R16-20250313","doi-asserted-by":"crossref","first-page":"e14155","DOI":"10.1111\/ctr.14155","article-title":"The economic impact of increased length of stay associated with surgical site infections in liver transplantation on Canadian healthcare cost.","volume":"35","author":"Natori","year":"2021","journal-title":"Clin Transplant"},{"key":"R17-20250313","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/152692481002000404","article-title":"Quality of surgical care in liver and small-bowel transplant: Approach to risk assessment and antibiotic prophylaxis.","volume":"20","author":"Kettelhut","year":"2010","journal-title":"Prog Transplant"},{"key":"R18-20250313","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/lt.21502","article-title":"Regarding the risk for development of surgical site infections and bacterial prophylaxis in liver transplantation.","volume":"14","author":"Kusne","year":"2008","journal-title":"Liver Transpl"},{"key":"R19-20250313","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1086\/501572","article-title":"The impact of surgical site infections in the 1990s: Attributable mortality, excess length of hospitalization, and extra costs.","volume":"20","author":"Kirkland","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R20-20250313","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies.","volume":"147","author":"Von Elm","year":"2007","journal-title":"Ann Intern Med"},{"key":"R21-20250313","article-title":"CDC-NHSN website."},{"key":"R22-20250313","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1111\/ajt.17189","article-title":"Epidemiology of surgical site infections after solid organ Transplants in the period 2015-2019: a single-center retrospective cohort study.","volume":"22","author":"Carugati","year":"2022","journal-title":"Am J Transplant"},{"key":"R23-20250313","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance.","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R25-20250313","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1214\/15-AOS1371","article-title":"Exact post selection inference with application to the lasso.","volume":"44","author":"Lee","year":"2016","journal-title":"Ann Statist"},{"key":"R26-20250313","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/TP.0b013e31819cc3e6","article-title":"Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation.","volume":"87","author":"Park","year":"2009","journal-title":"Transplantation"},{"key":"R27-20250313","first-page":"1179","article-title":"Risk factors for surgical site infections after liver transplant: Does perioperative antibiotic regimen matter?","volume":"108","author":"Rolak","year":"2023","journal-title":"Transplantation"},{"key":"R28-20250313","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1600-6143.2008.02304.x","article-title":"Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients.","volume":"8","author":"Russell","year":"2008","journal-title":"Am J Transplant"},{"key":"R30-20250313","doi-asserted-by":"crossref","first-page":"e13589","DOI":"10.1111\/ctr.13589","article-title":"Surgical site infections: guidelines from the American society of Transplantation Infectious Diseases Community of Practice.","volume":"33","author":"Abbo","year":"2019","journal-title":"Clin Transplant"},{"key":"R31-20250313","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2146\/ajhp120568","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery.","volume":"70","author":"Bratzler","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"R32-20250313","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/lt.25486","article-title":"Intraoperative versus extended antibiotic prophylaxis in liver transplant surgery: A randomized controlled pilot trial.","volume":"25","author":"Berry","year":"2019","journal-title":"Liver Transpl"},{"key":"R33-20250313","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1526924820933824","article-title":"Duration of perioperative antimicrobial prophylaxis in orthotopic liver transplantation patients.","volume":"30","author":"Bandali","year":"2020","journal-title":"Prog Transplant"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001719","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T17:02:16Z","timestamp":1741885336000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001719","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]}}}